AnaptysBio, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
55.91 |
79.39 |
89.82 |
116.00 |
109.71 |
160.57 |
| Przychód Δ r/r |
0.00% |
41.98% |
13.14% |
29.15% |
-5.43% |
46.36% |
| Przychód (min) |
47.36 |
20.40 |
89.80 |
36.58 |
34.60 |
50.64 |
| Przychód (max) |
63.12 |
117.15 |
89.84 |
262.88 |
248.62 |
363.88 |
| EBITDA (średnia) |
-46.30 |
-65.73 |
-74.37 |
-96.05 |
-90.84 |
-132.96 |
| EBIT (średnia) |
-46.75 |
-66.38 |
-75.10 |
-96.99 |
-91.73 |
-134.26 |
| EBIT % |
-83.61% |
-83.61% |
-83.61% |
-83.61% |
-83.61% |
-83.61% |
| Zysk netto (średni) |
-169.28 |
-151.88 |
-188.65 |
-272.14 |
-157.02 |
-125.21 |
| Zysk netto % |
-302.76% |
-191.31% |
-210.03% |
-234.59% |
-143.12% |
-77.98% |
| EPS (średnia) |
-6.08 |
-5.35 |
-4.97 |
-5.47 |
-5.53 |
-4.41 |
| Liczba analityków (Przychody) |
9 |
8 |
11 |
8 |
6 |
7 |
| Liczba analityków (EPS) |
9 |
8 |
9 |
8 |
7 |
6 |
| symbol |
ANAB |
ANAB |
ANAB |
ANAB |
ANAB |
ANAB |